Showing results (41-50 of 3,646) with videos related to
Sort By:
Pageof 365
Medizinische Klinik|December 21, 1979
[The range and lipid-lowering effect of etofibrate as a retard-preparation in patients with hyperlipoproteinemia type IIa (author's transl)]D P Mertz, H Loewer, I SuermannMMW, Munchener Medizinische Wochenschrift|August 25, 1978
[Clofibrate in type IIa hyperlipoproteinemia. Reduction of apolipoprotein B (author's transl)]D P Mertz, I Suermann, E GöhmannResearch in Experimental Medicine. Zeitschrift Fur Die Gesamte Experimentelle Medizin Einschliesslich Experimenteller Chirurgie|January 1, 1982
Bezafibrate: lack of effect on creatinine excretion and muscular proteinsD P Mertz, P D Lang, J VollmarKlinische Wochenschrift|November 1, 1977
[Action of benzbromarone on the renal excretion of allantoin in normouricemic and hyperuricemic humans (author's transl)]D Janzen, D P Mertz, E Scheiffele, et al.Medizinische Klinik|January 14, 1977
[Chances in the serum lipid values after conversion to a "reasonable" diet (author's transl)]D P Mertz, H D Wobbe, A Berger, et al.Medizinische Klinik|January 14, 1977
[Errors in practising a so-called "reasonable" regimen (author's transl)]H D Wobbe, D P Mertz, A Berger, et al.Journal of Pharmacokinetics and Biopharmaceutics|February 1, 1983
Hemodynamic influences upon the variance of disposition residence time distribution of drugsM WeissJournal of Mathematical Biology|January 1, 1984
A note on the rôle of generalized inverse Gaussian distributions of circulatory transit times in pharmacokineticsM WeissJournal of the Neurological Sciences|June 1, 1982
Rhythmic activity of spinal interneurons in harmaline-treated cats. A model for olivo-cerebellar influence at the spinal levelM WeissInternational Journal of Clinical Pharmacology, Therapy, and Toxicology|February 1, 1981
Residence time and accumulation of drugs in the bodyM WeissPageof 365